PAVmed Inc Asset Resilience Ratio
PAVmed Inc asset resilience ratio. PAVmed Inc (PAVM) has an Asset Resilience Ratio of 1.57% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PAVM days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of PAVmed Inc (2017–2024)
Asset resilience ratio of PAVmed Inc from 2017 to 2024. This chart shows how PAVmed Inc's Asset Resilience Ratio has changed over time. Read PAVM liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down PAVmed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PAVmed Inc assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $480.00K | 1.57% |
| Total Liquid Assets | $480.00K | 1.57% |
Asset Resilience Insights
- Limited Liquidity: PAVmed Inc maintains only 1.57% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PAVmed Inc Industry Peers by Asset Resilience Ratio
Compare PAVmed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
PAVmed Inc Asset Resilience Ratio by Year (2017–2024)
PAVmed Inc asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for PAVmed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.13% | $347.00K | $30.66 Million | -6.94pp |
| 2023-12-31 | 8.07% | $2.67 Million | $33.12 Million | +2.50pp |
| 2022-12-31 | 5.57% | $3.00 Million | $53.98 Million | +3.28pp |
| 2021-12-31 | 2.29% | $1.99 Million | $86.98 Million | +0.96pp |
| 2020-12-31 | 1.32% | $262.00K | $19.78 Million | +0.86pp |
| 2019-12-31 | 0.47% | $34.00K | $7.24 Million | -0.05pp |
| 2018-12-31 | 0.52% | $44.25K | $8.50 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $1.64 Million | -- |
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more